Iranians have left Doha talks, draft proposal for US deal being circulated, official says Reuters
Why DH Stock slipped -1.75% Today — RQD Quant Desk Flash
Definitive Healthcare Corp. (Class A) (DH) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is DH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Definitive Healthcare Corp. (Class A) (NASDAQ: DH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.12 (-1.75% 1D, market cap $162.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, DH ranks #384 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does DH compare to SWMR and EGAN in the Technology sector?
▼
Within the Technology sector (Computer Software: Prepackaged Software), DH carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 75.9%, and ROIC of -35.0%. By comparison, SWMR (Swarmer Inc) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $167.4M) and EGAN (eGain Corporation) posts a C- grade (59/100 RQD, P/E 4.7x, ROIC 46.7%, cap $150.1M). Among the 5-stock peer group, EGAN leads on earnings multiple (4.7x) while EGAN leads on capital efficiency (46.7% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for DH?
▼
Per DH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861795), Definitive Healthcare Corp. (Class A) generated $241.5M in revenue (-4.2% YoY), -$138.9M in net income, and $37.1M in free cash flow against $735.5M in total assets and $156.1M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
FRED Regime × Technicals: 21% of 52W Range • RSI-14 at 63.9 (BULLISH MOMENTUM)
20D Institutional Volume Accumulation (±10.8% realized swing band)
Capital intensity & 0% operating margin leave 16 pts on the table
⚔️ Adversarial Opposing Case: What Could Spark a DH Turnaround Squeeze
While DH currently carries a cautious 48/100 (D) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.99) and Max Pain ($1.18) forces dealer call-delta covering toward $3.15.
Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.96% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why DH Stock slipped -1.75% Today — RQD Quant Desk Flash
Definitive Healthcare Corp. (Class A) (DH) slipped -1.75% to $1.12, trading at 21% of its 52-week range ($0.61 – $3). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 21% of its 52-week range ($0.61 – $3) with RSI-14 at 63.9 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±10.8% around $1.12 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 75.9% gross margin and $37.1M annual free cash flow.
COMMENTARY: Asia's crude oil imports back to pre-war levels but refined fuels lag Reuters
Saudi civil defence sounds all-clear after alerts in southern cities Reuters
World's energy supply buffers have been eroded, ADNOC CEO says Reuters
Gold rises on softer oil; markets parse Fed signals Reuters
China's Xi says Middle East should not become battleground for great power rivalry Reuters
Reliance earnings, lower oil prices power India's Sensex to near two-month high Reuters
Dollar pulls back ahead of US midterms; bitcoin stabilises after crypto heist Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DH)
- ✓Walkthrough of DH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
DH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -4.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on DH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for DH. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DH)
1. Head-to-Head Technology Peer Comparison (DH vs. SWMR, EGAN, HUCK, AEYE)
Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, Definitive Healthcare Corp. (Class A) (DH) ranks #384 by composite RQD confidence (48/100, grade D) and #498 by equity capitalization ($162.4M). Within this direct 5-issuer industry benchmark cohort, EGAN leads on earnings valuation at 4.7x trailing P/E, while EGAN leads on capital efficiency and profitability with 46.7% ROIC and 70.1% gross margin. EGAN currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with DH at 48/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DH
ACTIVE
Definitive Healthcare Corp. (Class A) | D | 48/100 | — | 75.9% | -35.0% | -1.75% | $162.4M | Benchmark Subject |
| SWMR Swarmer Inc | E | 26/100 | — | 41.2% | -35.0% | +12.84% | $167.4M | /swmr-vs-dh → |
| EGAN eGain Corporation | C- | 59/100 | 4.7x | 70.1% | 46.7% | +2.42% | $150.1M | /egan-vs-dh → |
| HUCK Huckleberry.ai Inc. (Class B) | E | 29/100 | — | 75.0% | -35.0% | +0.97% | $147.7M | /huck-vs-dh → |
| AEYE AudioEye Inc. | D | 46/100 | — | 78.3% | -12.1% | +18.26% | $179.1M | /aeye-vs-dh → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001861795In its most recent audited fiscal period (FY2025, filed 2025-12-31), Definitive Healthcare Corp. (Class A) (DH) reported GAAP revenue of $241.5M (-4.2% vs. FY2024 revenue of $252.2M , and -3.9% cumulative change since FY2023) , GAAP net income of -$138.9M, operating cash flow of $53.8M, and free cash flow of $37.1M (-19.2% YoY). On the balance sheet, DH closed FY2025 with $735.5M in total assets against $156.1M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $241.5M | -$138.9M | $53.8M | $37.1M | $735.5M | $156.1M |
| FY2024 (FY) | 2024-12-31 | $252.2M | -$413.1M | $58.2M | $45.9M | $1.09B | $229.4M |
| FY2023 (FY) | 2023-12-31 | $251.4M | -$202.4M | $41.2M | $41.2M | — | — |
3. DH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Definitive Healthcare Corp. (Class A) (NASDAQ: DH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.12 (-1.75% 1D, market cap $162.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, DH ranks #384 in composite RQD confidence.
How does DH compare to SWMR and EGAN in the Technology sector?
Within the Technology sector (Computer Software: Prepackaged Software), DH carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 75.9%, and ROIC of -35.0%. By comparison, SWMR (Swarmer Inc) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $167.4M) and EGAN (eGain Corporation) posts a C- grade (59/100 RQD, P/E 4.7x, ROIC 46.7%, cap $150.1M). Among the 5-stock peer group, EGAN leads on earnings multiple (4.7x) while EGAN leads on capital efficiency (46.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DH?
Per DH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861795), Definitive Healthcare Corp. (Class A) generated $241.5M in revenue (-4.2% YoY), -$138.9M in net income, and $37.1M in free cash flow against $735.5M in total assets and $156.1M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DH trading relative to its 50-day, 200-day, and 52-week technical levels?
DH last traded at $1.12 (-1.75% on volume of 335,782 shares), positioning the stock +13.13% above its 50-day simple moving average ($0.99) and +4.67% above its 200-day simple moving average ($1.07). Across its 52-week range of $0.61 to $3.00, DH sits at the 21.3% percentile with a 14-day RSI of 63.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±10.8% ($1.00 to $1.24).
DH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is DH stock moving today?
Why DH Stock slipped -1.75% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.